EHRs A Vehicle For Delivering REMS Data To Physicians – FDA’s Woodcock
Executive Summary
PHILADELPHIA – FDA is looking at electronic health records to serve as a vehicle for pushing details of Risk Evaluation and Mitigation Strategies to physicians, FDA Center for Drug Evaluation and Research Director Janet Woodcock said.
You may also be interested in...
EHRs A Tool For Drug Label Communications, Adverse Event Reporting And Adherence – FDA’s Woodcock
FDA’s vision for electronic health records is being incorporated into a new application launched by PDR Network.
Sentinel Initiative Needs Better Defined Goals, Outside Review Concludes
The Pharmacovigilance Review Subcommittee of FDA's Science Board reports a lack of clarity within CDER over just what purpose the drug safety program is supposed to serve.
FDA's Chicken Or Egg Question For Pharmacy Leaflets: Should Benefit Or Risk Come First?
FDA will look at which should come first – benefits or risks – when it studies patients' response to three one-page prototypes of patient medication information.